Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

July 18, 2016 07:34 ET | Source: EQS Group AG

DGAP-News: RedHill Biopharma Ltd.: RedHill Biopharma and IntelGenx Announce Definitive Agreement for Commercialization of RIZAPORT(TM) for Migraines with Grupo JUSTE in Spain and Additional Potential Territories

DGAP-News: RedHill Biopharma Ltd. / Key word(s): Contract RedHill Biopharma Ltd.: RedHill Biopharma and IntelGenx Announce Definitive Agreement for Commercialization of RIZAPORT(TM) for Migraines with...
July 18, 2016 06:49 ET | Source: Radiant Insights

Digestive Health Food and Drinks Market Likely To Experience A CAGR Of 8% By 2018 : Radiant Insights,Inc

San Francisco, July 18, 2016 (GLOBE NEWSWIRE) -- Digestive health food and drinks are mainly designed to relieve the signs of an overstrained digestive tract. The global digestive health food and...
July 13, 2016 07:00 ET | Source: RedHill Biopharma Ltd.

RedHill Biopharma Announces Research Collaboration with NIH for Potential Ebola Treatment

TEL-AVIV, Israel, July 13, 2016 (GLOBE NEWSWIRE) -- RedHill Biopharma Ltd. (NASDAQ:RDHL) (TASE:RDHL) (“RedHill” or the “Company”), a biopharmaceutical company primarily focused on development and...
July 06, 2016 11:13 ET | Source: Research and Markets

Global Autoimmune Disease Diagnostics Market 2016-2020 with Abbott Laboratories, Beckman Coulter, Bio-Rad Laboratories, Inova Diagnostics, Siemens Healthcare & Thermo Fisher Scientific Dominating

Dublin, July 06, 2016 (GLOBE NEWSWIRE) -- Research and Markets has announced the addition of the "Global Autoimmune Disease Diagnostics Market 2016-2020" report to their offering. ...
July 05, 2016 09:00 ET | Source: IntelGenx Technologies Corp.

IntelGenx and RedHill Biopharma Announce Signing of Definitive Agreement for Commercialization of RIZAPORT(TM) with Grupo Juste for Spain and Additional Potential Territories

SAINT-LAURENT, QUEBEC--(Marketwired - July 5, 2016) - IntelGenx Corp., (TSX VENTURE:IGX)(OTCQX:IGXT), and RedHill Biopharma Ltd. (NASDAQ:RDHL)(TASE:RDHL), today announced the signing of...
July 05, 2016 09:00 ET | Source: RedHill Biopharma Ltd.

RedHill Biopharma and IntelGenx Announce Definitive Agreement for Commercialization of RIZAPORT™ for Migraines with Grupo JUSTE in Spain and Additional Potential Territories

RedHill and its co-development partner, IntelGenx, have signed a definitive agreement with Grupo JUSTE granting an exclusive license to commercialize their acute migraine drug RIZAPORT™ in...
July 05, 2016 03:10 ET | Source: EQS Group AG

DGAP-News: RedHill Biopharma Ltd.: RedHill Biopharma Announces Publication Demonstrating Potential Efficacy of RHB-104 for Crohn's Disease Associated with MAP Infection

DGAP-News: RedHill Biopharma Ltd. / Key word(s): Scientific publication RedHill Biopharma Ltd.: RedHill Biopharma Announces Publication Demonstrating Potential Efficacy of RHB-104 for Crohn's Disease...
July 05, 2016 02:12 ET | Source: TiGenix

Takeda and TiGenix Enter into Licensing Agreement for Ex-U.S. rights to Cx601 for the Treatment of Complex Perianal Fistulas in Patients with Crohn's Disease

OSAKA, Japan and LEUVEN, Belgium, July 5, 2016 (GLOBE NEWSWIRE) -- Takeda Pharmaceutical Company Limited (TSE: 4502) ("Takeda") and TiGenix NV (Euronext Brussels: TIG) ("TiGenix") today announced that...
July 05, 2016 02:00 ET | Source: TiGenix

Takeda and TiGenix Enter into Licensing Agreement for Ex-U.S. rights to Cx601 for the Treatment of Complex Perianal Fistulas in Patients with Crohn's Disease

body { font-family: Arial, Verdana, Helvetica; font-size: 13px;} table.hugin { border-color:black;} td.hugin { padding: 3px; border-color:black;} PRESS RELEASEREGULATED INFORMATION ...
July 05, 2016 02:00 ET | Source: TiGenix

TiGenix reconfirms its strategic focus on its allogeneic stem cell platforms

body { font-family: Arial, Verdana, Helvetica; font-size: 13px;} table.hugin { border-color:black;} td.hugin { padding: 3px; border-color:black;} REGULATED INFORMATIONPRESS RELEASE ...